Abstract

The heart is an extraordinarily versatile pump, finely tuned to respond to a multitude of demands. Given the heart pumps without rest for decades its efficiency is particularly relevant. Although many proteins in the heart are essential for viability, the non-essential components can attract numerous mutations which can cause disease, possibly through alterations in pumping efficiency. Of these, myosin binding protein C is strongly over-represented with ~ 40% of all known mutations in hypertrophic cardiomyopathy. Therefore, a complete understanding of its molecular function in the cardiac sarcomere is warranted. In this review, we revisit contemporary and classical literature to clarify both the current standing of this fast-moving field and frame future unresolved questions. To date, much effort has been directed at understanding MyBP-C function on either thick or thin filaments. Here we aim to focus questions on how MyBP-C functions at a molecular level in the context of both the thick and thin filaments together. A concept that emerges is MyBP-C acts to govern interactions on two levels; controlling myosin access to the thin filament by sequestration on the thick filament, and controlling the activation state and access of myosin to its binding sites on the thin filament. Such affects are achieved through directed interactions mediated by phosphorylation (of MyBP-C and other sarcomeric components) and calcium.

Highlights

  • Structure/localisationMuscle contraction and relaxation on the molecular level is achieved by the sliding movement of interdigitating thick filaments containing myosin and thin filaments containing actin in the sarcomere

  • Myosin binding protein C (MyBP-C) is a sarcomeric accessory protein that was first identified as a contaminant of crude skeletal muscle preparation (Starr and Offer 1971)

  • Slow skeletalMyBP-C is encoded by MYBPC1 on chromosome 12, fast skeletalMyBP-C by MYBPC2 on chromosome 19 and cardiac (c)MyBP-C by MYBPC3 on chromosome 11. cMyBP-C was discovered after ssMyBP-C and fsMyBP-C (Hartzell and Titus 1982; Yamamoto and Moos 1983), and as the name suggests is exclusive to cardiac muscle

Read more

Summary

Introduction

Structure/localisationMuscle contraction and relaxation on the molecular level is achieved by the sliding movement of interdigitating thick filaments containing myosin and thin filaments containing actin in the sarcomere. It was shown using N-terminal MyBP-C fragments (C1-m-C2) that the functional and structural effects of phosphorylation in interaction with the thin filament are not mimicked by this substitution (Kampourakis et al 2018).

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.